Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial Study Design and Rationale
Title:
Randomised, Double-Blind, Placebo-Controlled Trial of Ivabradine in Patients with Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine on Reduction of Inflammation Markers in Patients with Acute Coronary Syndrome—RIVIERA Trial Study Design and Rationale
Author:
Dominguez-Rodriguez, Alberto Fard, Sima Samimi Abreu-Gonzalez, Pedro Bosa-Ojeda, Francisco Consuegra-Sanchez, Luciano Jiménez-Sosa, Alejandro Grande, Alejandro Sánchez Kaski, Juan Carlos